Malignant fibrous histiocytoma after allogeneic bone marrow transplantation

A 24-year-old woman with CML underwent allogeneic BMT in August 1995 from a one-antigen HLA mismatched brother. Conditioning included BuCy2 and CsA and MTX were used to prevent GVHD. In July 1997 she developed right leg pain, lytic bone lesions of distal femur and a solid mass of soft tissue. Histol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 1999-11, Vol.24 (9), p.1029-1031
Hauptverfasser: VELA-OJEDA, J, DIAZ DE LEON, L, TRIPP-VILLANUEVA, F, SANCHEZ-CORTES, E, AYALA-SANCHEZ, M, GARCIA-RUIZ ESPARZA, M, ROSAS-CABRAL, A, GONZALEZ-LLAVEN, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A 24-year-old woman with CML underwent allogeneic BMT in August 1995 from a one-antigen HLA mismatched brother. Conditioning included BuCy2 and CsA and MTX were used to prevent GVHD. In July 1997 she developed right leg pain, lytic bone lesions of distal femur and a solid mass of soft tissue. Histological diagnosis of malignant fibrous histiocytoma was made. Despite treatment with surgery and chemotherapy (doxorubicin and ifosfamide), the patient died 1 year later with local recurrence of the tumor and liver, lung and brain metastases. The CML was in CR.
ISSN:0268-3369
1476-5365
DOI:10.1038/sj.bmt.1701919